Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Date
2017
Author
Yazici, H.
Esatoglu, S. N.
Hamuryudan, V.
Hatemi, G.
Ucar, Didar
Ozyazgan, Y.
Yurdakul, S.
Seyahi, E.
Guzelant, G.
Metadata
Show full item record
Abstract
Objective. The prognosis of uveitis in Behcet's syndrome (BS) has improved over decades. Whether this is related to the use of more aggressive management strategies is not known.
URI
http://hdl.handle.net/20.500.12627/88285
Collections